KingMed
金域医学 (KingMed) offers Clinical-trial central laboratory and biomarker testing. Services should be matched to the intended study and assay requirements.
Corporate information
- Company entity
- 金域医学 (KingMed)
- Ownership / capital status
- Publicly tradedPublicly listed; see issuer disclosures ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗ ↗
- Official corporate reference
- https://kingmed.com.cn/ ↗
- LinkedIn company page
- LinkedIn ↗ ↗
Profile review: 2026-11-05 · Fields retain their individual source dates. Undisclosed values are not zero; early or historical events do not establish the latest financing. Awards and acquisitions are distinguished from equity rounds.
Discuss this company with the research assistant
Start with public sources and capability boundaries; company claims are not independent certification.
Ask AI ↗Public evidence snapshot
金域医学 (KingMed) offers Clinical-trial central laboratory and biomarker testing. Services should be matched to the intended study and assay requirements.
This profile is a research snapshot, not a company endorsement. Check original sources for current information.
Original sources
- 金域医学与PPC佳生集团展开合作，携手为临床试验提供优质服务-[金域医学]
- Kingmed Diagnostics | LinkedIn
- 中心实验室服务-独立医学实验室-第三方医学实验室-[金域医学]
- 为广州市生物医药研发“添翼”，金域与广州市创新药物临床试验服务中心签约-[金域医学]